PharmAgents2: Towards Autonomous End-to-End Drug Discovery

arXiv cs.AI 约 12 分钟读完

Drug discovery requires continuous scientific decision-making across a vast research space. We introduce PharmAgents2, an autonomous system for end-to-end drug discovery that combines knowledge-enhanced decision-making with organized large-scale exploration. Paper2Skill extracts transferable scienti…

Authors: Haichuan Tan , Bowen Gao , Tao Huang , Jiaxin Tan , Xin Hong , Baoguo Yao , Yifei Wang , Zhichao Deng , Hanji Du , Dapeng Jiang , Yiheng Li , Weiwei Ma , Xin Ma , Yuqi Shi , Zixiang Wang , Kelin Wu , Tianxiang Wu , Wenxuan Xie , Jie Zang , Huiyu Zhang , Mojia Zhang , Yuying Zhang , Ya-Qin Zhang , Wei-Ying Ma , Yanyan Lan

View a PDF of the paper titled PharmAgents2: Towards Autonomous End-to-End Drug Discovery, by Haichuan Tan and 24 other authors

View PDF

HTML (experimental)

Abstract: Drug discovery requires continuous scientific decision-making across a vast research space. We introduce PharmAgents2, an autonomous system for end-to-end drug discovery that combines knowledge-enhanced decision-making with organized large-scale exploration. Paper2Skill extracts transferable scientific decision knowledge from public sources and, together with expert-developed skills, supports research decisions. Self-Scaling Discovery expands exploration through parallel agents inheriting research context and decision-making capabilities across targets, scientific hypotheses, and discovery strategies. We introduce PharmAgents-Bench v0.1, comprising 121 questions across nine decision scenarios and three end-to-end tasks assessed with expert-defined process rubrics. PharmAgents2 outperforms evaluated baselines in most decision categories and achieves the highest process scores on all three end-to-end tasks. In three real-world studies, autonomous investigations generated findings subsequently supported by human-executed experiments. For LpxH, PharmAgents2 hypothesized a previously unreported allosteric site and screened compounds against it, identifying a novel inhibitor scaffold with experimentally confirmed inhibitory activity and binding. For JAK1, it prioritized a covalent inhibition strategy and nominated compounds with experimentally demonstrated activity. Starting from a known bioactive molecule, Self-Scaling Discovery explored candidate targets across the proteome and identified a new binding target, with the interaction subsequently confirmed experimentally. PharmAgents2 represents a prototype of a virtual pharmaceutical company, marking a step toward autonomous end-to-end drug discovery.

Subjects:

Artificial Intelligence (cs.AI) ; Quantitative Methods (q-bio.QM)

Cite as:

arXiv:2611.07653 [cs.AI]

(or

arXiv:2611.07653v1 [cs.AI] for this version)

https://doi.org/10.48550/arXiv.2611.07653

Focus to learn more

arXiv-issued DOI via DataCite (pending registration)

Submission history

From: Haichuan Tan [ view email ]

[v1]

Thu, 5 Nov 2026 08:39:19 UTC (19,231 KB)

Full-text links:

Access Paper:

View a PDF of the paper titled PharmAgents2: Towards Autonomous End-to-End Drug Discovery, by Haichuan Tan and 24 other authors

View PDF

HTML (experimental)

TeX Source

view license

Additional Features

Audio Summary

Current browse context:

cs.AI

< prev

next >

new

recent

| 2026-11

Change to browse by:

cs

q-bio

q-bio.QM

References & Citations

SciX

Google Scholar

Semantic Scholar

export BibTeX citation

Loading...

BibTeX formatted citation

loading...

Data provided by:

Bookmark

Bibliographic Tools

Bibliographic and Citation Tools

Bibliographic Explorer Toggle

Bibliographic Explorer ( What is the Explorer? )

Connected Papers Toggle

Connected Papers ( What is Connected Papers? )

Litmaps Toggle

Litmaps ( What is Litmaps? )

scite.ai Toggle

scite Smart Citations ( What are Smart Citations? )

Code, Data, Media

Code, Data and Media Associated with this Article

alphaXiv Toggle

alphaXiv ( What is alphaXiv? )

Links to Code Toggle

CatalyzeX Code Finder for Papers ( What is CatalyzeX? )

DagsHub Toggle

DagsHub ( What is DagsHub? )

GotitPub Toggle

Gotit.pub ( What is GotitPub? )

Huggingface Toggle

Hugging Face ( What is Huggingface? )

ScienceCast Toggle

ScienceCast ( What is ScienceCast? )

Demos

Demos

Replicate Toggle

Replicate ( What is Replicate? )

Spaces Toggle

Hugging Face Spaces ( What is Spaces? )

Spaces Toggle

TXYZ.AI ( What is TXYZ.AI? )

Related Papers

Recommenders and Search Tools

Link to Influence Flower

Influence Flower ( What are Influence Flowers? )

Core recommender toggle

CORE Recommender ( What is CORE? )

Author

Venue

Institution

Topic

About arXivLabs

arXivLabs: experimental projects with community collaborators

arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.

Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.

Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs .

Which authors of this paper are endorsers? |

Disable MathJax ( What is MathJax? )

原文标题 PharmAgents2: Towards Autonomous End-to-End Drug Discovery
引用来源 arXiv cs.AI
本地存档 2026-11-06 13:05
引用格式 Haichuan Tan, Bowen Gao, Tao Huang, Jiaxin Tan, Xin Hong, Baoguo Yao, Yifei Wang. PharmAgents2: Towards Autonomous End-to-End Drug Discovery. 2026-11-06. https://www.ai007.site/news/159091

本文内容由 ai007 从公开渠道聚合,版权归原作者所有。若原文已删除或变更, 以原文站为准;本站存档仅为便于查阅而保留。